VIVA BIOTECH has completed the sale of a 2.33% equity stake in Viva Shanghai.

智通財經
2023.12.27 09:47

維亞生物公告稱，已完成出售維亞上海 2.33% 股權的相關事宜，股權轉讓的先決條件已達成。完成後，Raed Capital Holdings 2Ltd 將持有維亞上海 2.33% 股權，維亞生物對維亞上海的權益減少至 73.46%。維亞上海仍為維亞生物的附屬公司，財務業績繼續綜合入賬至集團財務報表。

智通財經 APP 訊，維亞生物 (01873) 發佈公告，內容有關出售維亞上海的 2.33% 股權的相關事宜，股權轉讓的所有先決條件已獲達成，且完成已於 2023 年 12 月 27 日落實。完成後，Raed Capital Holdings 2Ltd 於維亞上海註冊資本約 2.33% 中擁有權益，而集團於維亞上海的權益則由約 75.79% 減少至 73.46%，且維亞上海仍為公司一間附屬公司，其財務業績將繼續綜合入賬至集團財務報表。

Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.